Asymmetric Cation-Olefin Monocyclization by Engineered Squalene–Hopene Cyclases

Journal Article (2021)
Author(s)

Michael Eichenberger (Zurich University of Applied Science (ZHAW))

Sean Hüppi (Zurich University of Applied Science (ZHAW), TU Delft - Applied Sciences)

David Patsch (Zurich University of Applied Science (ZHAW), Greifswald University)

Natalie Aeberli (Fragrances S & T, Kemptthal)

Raphael Berweger (Fragrances S & T, Kemptthal)

Sandro Dossenbach (Fragrances S & T, Kemptthal)

Eric Eichhorn (Fragrances S & T, Kemptthal)

Felix Flachsmann (Fragrances S & T, Kemptthal)

Lucas Hortencio (Fragrances S & T, Kemptthal)

undefined More Authors (External organisation)

Research Group
BT/Biocatalysis
DOI related publication
https://doi.org/10.1002/anie.202108037 Final published version
More Info
expand_more
Publication Year
2021
Language
English
Research Group
BT/Biocatalysis
Issue number
50
Volume number
60
Pages (from-to)
26080-26086
Downloads counter
315
Collections
Institutional Repository
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Squalene–hopene cyclases (SHCs) have great potential for the industrial synthesis of enantiopure cyclic terpenoids. A limitation of SHC catalysis has been the enzymes’ strict (S)-enantioselectivity at the stereocenter formed after the first cyclization step. To gain enantio-complementary access to valuable monocyclic terpenoids, an SHC-wild-type library including 18 novel homologs was set up. A previously not described SHC (AciSHC) was found to synthesize small amounts of monocyclic (R)-γ-dihydroionone from (E/Z)-geranylacetone. Using enzyme and process optimization, the conversion to the desired product was increased to 79 %. Notably, analyzed AciSHC variants could finely differentiate between the geometric geranylacetone isomers: While the (Z)-isomer yielded the desired monocyclic (R)-γ-dihydroionone (>99 % ee), the (E)-isomer was converted to the (S,S)-bicyclic ether (>95 % ee). Applying the knowledge gained from the observed stereodivergent and enantioselective transformations to an additional SHC-substrate pair, access to the complementary (S)-γ-dihydroionone (>99.9 % ee) could be obtained.